Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

L3MBTL1, a histone-methylation-dependent chromatin lock.

Cell | Jun 1, 2007

http://www.ncbi.nlm.nih.gov/pubmed/17540172

Distinct histone lysine methylation marks are involved in transcriptional repression linked to the formation and maintenance of facultative heterochromatin, although the underlying mechanisms remain unclear. We demonstrate that the malignant-brain-tumor (MBT) protein L3MBTL1 is in a complex with core histones, histone H1b, HP1gamma, and Rb. The MBT domain is structurally related to protein domains that directly bind methylated histone residues. Consistent with this, we found that the L3MBTL1 MBT domains compact nucleosomal arrays dependent on mono- and dimethylation of histone H4 lysine 20 and of histone H1b lysine 26. The MBT domains bind at least two nucleosomes simultaneously, linking repression of transcription to recognition of different histone marks by L3MBTL1. Consistently, L3MBTL1 was found to negatively regulate the expression of a subset of genes regulated by E2F, a factor that interacts with Rb.

Pubmed ID: 17540172 RIS Download

Mesh terms: Cell Line | Chromatin | Chromatin Immunoprecipitation | Chromosomal Proteins, Non-Histone | E2F Transcription Factors | HeLa Cells | Histones | Humans | Methylation | Neoplasm Proteins | Nucleosomes | Protein Binding | Retinoblastoma Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA 102202
  • Agency: NCI NIH HHS, Id: CA085826
  • Agency: NCI NIH HHS, Id: CA113863
  • Agency: NIGMS NIH HHS, Id: GM-64844
  • Agency: NIGMS NIH HHS, Id: GM-71166

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.